Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Medicinal Chemistry|June 20, 2019
Small-Molecule CSF1R Inhibitors as Anticancer AgentsQiuju Xun, Zhen Wang, Xianglong Hu, et al.European Journal of Medicinal Chemistry|February 5, 2025
Discovery of BW710 as a potent, selective and orally bioavailable fibroblast growth factor receptor 2 (FGFR2) inhibitorBowen Yang, Qiuju Xun, Yuan Tian, et al.European Journal of Medicinal Chemistry|December 19, 2025
Synthesis and optimization of LHQ766: A highly selective FGFR2 inhibitor with improved pharmacokineticsHuiqiong Li, Qiuju Xun, Bowen Yang, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|March 30, 2026
2<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-amine derivatives as novel selective fibroblast growth factor receptor 2 (FGFR2) inhibitorsPinglian Wu, Zhaodi Tian, Weizhong Shen, et al.Journal of Medicinal Chemistry|March 3, 2018
Design, Synthesis, and Structure-Activity Relationship Study of 2-Oxo-3,4-dihydropyrimido[4,5- d]pyrimidines as New Colony Stimulating Factor 1 Receptor (CSF1R) Kinase InhibitorsQiuju Xun, Zhang Zhang, Jinfeng Luo, et al.ACS Medicinal Chemistry Letters|March 25, 2017
Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) InhibitorsZhen Wang, Yali Zhang, Sergio G Bartual, et al.ACS Medicinal Chemistry Letters|November 16, 2018
Discovery of JND3229 as a New EGFR<sup>C797S</sup> Mutant Inhibitor with In Vivo Monodrug EfficacyXiaoyun Lu, Tao Zhang, Su-Jie Zhu, et al.Journal of Medicinal Chemistry|August 5, 2018
Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2- a]pyrazin-3-ylethynyl)-4-isopropyl- N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2Zhen Wang, Yali Zhang, Daniel M Pinkas, et al.Pageof 1